CGRNX
Price
$32.90
Change
+$0.20 (+0.61%)
Updated
Oct 17 closing price
Net Assets
782.11M
RMFCX
Price
$61.51
Change
+$0.17 (+0.28%)
Updated
Oct 17 closing price
Net Assets
111.18B
Interact to see
Advertisement

CGRNX vs RMFCX

Header iconCGRNX vs RMFCX Comparison
Open Charts CGRNX vs RMFCXBanner chart's image
Invesco Comstock Select R
Price$32.90
Change+$0.20 (+0.61%)
VolumeN/A
Net Assets782.11M
American Funds American Mutual R3
Price$61.51
Change+$0.17 (+0.28%)
VolumeN/A
Net Assets111.18B
CGRNX vs RMFCX Comparison Chart in %
View a ticker or compare two or three
VS
CGRNX vs. RMFCX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGRNX is a Hold and RMFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 111B vs. CGRNX (782M). RMFCX (1.20) and CGRNX (1.16) have matching dividends . CGRNX was incepted earlier than RMFCX: CGRNX (25 years) vs RMFCX (23 years). CGRNX (1.18) is less costly to investors than RMFCX (0.91). CGRNX is a more actively managed with annual turnover of: 70.00 vs. RMFCX (31.00). CGRNX has a lower initial minimum investment than RMFCX: CGRNX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 4.96 vs. CGRNX (-5.01). RMFCX return over 5 years is better than : 57.10 vs. CGRNX (50.17).
CGRNXRMFCXCGRNX / RMFCX
Total Expense Ratio1.180.91130%
Annual Report Gross Expense Ratio1.180.91130%
Fund Existence25 years23 years-
Gain YTD11.10513.68981%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets782M111B1%
Annual Yield % from dividends1.161.2097%
Returns for 1 year-5.014.96-101%
Returns for 3 years8.9238.7923%
Returns for 5 years50.1757.1088%
Returns for 10 years21.3791.1823%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UDR36.090.18
+0.50%
UDR
ASPC10.360.01
+0.10%
A Spac III Acquisition Corp
VERO2.30-0.05
-2.13%
Venus Concept
AMRC39.93-2.68
-6.29%
Ameresco
CGEM7.86-0.89
-10.13%
Cullinan Therapeutics